Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma

Wang, Yu-TingYu-TingWangChang, Il-ChiIl-ChiChangChen, Chih-YiChih-YiChenHsia, Jiun-YiJiun-YiHsiaLin, Frank Cheau-FengFrank Cheau-FengLinChao, Wan-RuWan-RuChaoKe, Tuan-YingTuan-YingKeChen, Ya-TingYa-TingChenChen, Chih-JungChih-JungChenMIN-SHU HSIEHHuang, Shiu-FengShiu-FengHuang2023-10-312023-10-312023-0217597706https://scholars.lib.ntu.edu.tw/handle/123456789/636708The eighth edition of the American Joint Committee on Cancer (AJCC) staging system for lung cancer adopts new criteria for tumor size, and for determining pTis, pT1a(mi), and pT1a. The latter is based on the size of stromal invasion. It is quite challenging for lung pathologists.enAJCC staging system; adenocarcinoma in situ; lung adenocarcinoma; minimally invasive adenocarcinoma; recurrence[SDGs]SDG3Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinomajournal article10.1111/1759-7714.14785365941112-s2.0-85145451581https://api.elsevier.com/content/abstract/scopus_id/85145451581